Sonia Extremera

Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma

María‐Victoria Mateos, María Teresa Cibeira, Paul G. Richardson et al. · Clinical Cancer Research · 2010 · 74 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +13

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Ivan Špıčka, Enrique M. Ocio, Heather Oakervee et al. · Annals of Hematology · 2019 · 57 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Herlinde Dumez, Enrique Gallardo, Stéphane Culine et al. · Marine Drugs · 2009 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis

Arturo Soto-Matos, Sergio Szyldergemajn, Sonia Extremera et al. · Marine Drugs · 2011 · 15 citations · Full text

Medicine, Cardiology, Pharmacology +12

Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas

Sandrine Aspeslagh, Mark N. Stein, Rastilav Bahleda et al. · Anti-Cancer Drugs · 2016 · 12 citations

Pharmacy, Oncology, Pharmacotherapy +11